News | Implantable Cardioverter Defibrillator (ICD) | April 13, 2018

Online Message Board Advice on ICDs Reflects Inaccuracies

Medical advice about implanted cardiac defibrillators obtained over two years from a dedicated online message board was accurate only about half of the time.

Online Message Board Advice on ICDs Reflects Inaccuracies

April 13, 2018 — Medical advice about implanted cardiac defibrillators obtained via an online message board appears to be accurate only half of the time, according to new preliminary research. The research was presented at the American Heart Association’s (AHA) Quality of Care and Outcomes Research Scientific Sessions 2018, April 6-7 in Arlington, Va.

The study was based on analysis of two years of messages on an anonymous online board about implanted cardiac defibrillators (ICDs). Results showed that about 25 percent of the messages contained inappropriate advice, and 6 percent of advice shared was controversial. Researchers analyzed 127 discussions, 82 of which pertained to medical advice in several topical areas, including cardiovascular disease, device programming and maintenance, physical activity restrictions and management of other health conditions.

The research team said the findings underscore the need to ensure that clinicians follow up with patients about their information sources to ensure they are receiving accurate advice outside of the doctor’s offices. Ensuring appropriate advice is particularly important when it comes to complex decisions about advanced procedures, tests and interventions such as the decision to have an ICD, the study authors added.

“The internet is a critical piece of the vast network of information available to patients, as Americans use the internet to understand their health all the time,” said Christopher Knoepke, Ph.D., study lead investigator and an instructor of cardiology at the University of Colorado Denver. “Our findings indicate that patients should be advised that discussions on these online message boards can provide some good, basic information, but more complicated and in-depth advice may be problematic.”

ICDs are miniature devices surgically implanted in the heart to fire off electric shocks that interrupt potentially lethal arrhythmias and restore normal heart rhythm. Between 1 and 2 million people live with ICDs in the United States, the study authors said, and some 130,000 new devices are implanted in patients each year.  

Given how common patient use of online medical information is, clinicians must be aware of the potential their patients will be exposed to inaccurate or dangerous information, the research team said.

“Clinicians should caution patients it’s impossible for anyone not familiar with his or her case and full medical history to help put information into context for their individual patient needs,” Knoepke said.

Co-authors are Daniel Slack, Daniel Matlock and Lucas Marzec. Author disclosures are on the abstract.

For more information: www.heart.org

 


Related Content

News | Cardiovascular Clinical Studies

Nov. 18, 2024 — Silence Therapeutics presented end-of-treatment data from its Phase 2 ALPACAR-360 study of zerlasiran, a ...

Home November 18, 2024
Home
News | Cardiovascular Clinical Studies

Aug. 15, 2024 — According to a new study being presented at ACC Asia 2024 in Delhi, India, drinking over 400 mg of ...

Home August 14, 2024
Home
Videos | Cardiovascular Clinical Studies

As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits ...

Home July 30, 2024
Home
News | Cardiovascular Clinical Studies

July 25, 2024 — BioCardia, Inc., a global leader in cellular and cell-derived therapeutics for the treatment of ...

Home July 25, 2024
Home
News | Cardiovascular Clinical Studies

July 18, 2024 — Elucid, a pioneering AI medical technology company providing physicians with imaging analysis software ...

Home July 18, 2024
Home
News | Cardiovascular Clinical Studies

July 10, 2024 — CellProthera, a private company specializing in cell-based therapies for repairing ischemic tissues, and ...

Home July 10, 2024
Home
News | Cardiovascular Clinical Studies

July 9, 2024 — Microbot Medical Inc. announced the completion of the first procedure in a patient utilizing its LIBERTY ...

Home July 09, 2024
Home
News | Cardiovascular Clinical Studies

June 26, 2024 — Semaglutide, a medication initially developed for type 2 diabetes and obesity, significantly improves ...

Home June 26, 2024
Home
News | Cardiovascular Clinical Studies

June 21, 2024 — Lexicon Pharmaceuticals, Inc. announced that the peer-reviewed Journal of the American College of ...

Home June 21, 2024
Home
News | Cardiovascular Clinical Studies

June 20, 2024 — Microbot Medical Inc. announced its agreement with Brigham and Women’s Hospital (BWH), a leading ...

Home June 20, 2024
Home
Subscribe Now